Happitech, an Amsterdam-based digital health firm, has announced the launch of FastStart Research application to further the adoption of digital health in cardiac practises and to support researchers. This research-focused mobile application employs photoplethysmography (PPG), a non-invasive technique that makes use of light to observe changes occurring in blood volume in the microvasculature. This technology measures heart rate, atrial fibrillation, and heart rate variability. The smartphone application is easily accessible to researchers around the world. The founder and CEO of Happitech, Yosef Safi Harb, says that the app equips researchers with the tools necessary to conduct research. Happitech has embarked on the journey of supporting cardiac researchers to make advancements.
Read More from Dicardiology
